Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2022 1
2023 1
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

4 results

Results by year

Filters applied: . Clear all
Page 1
Overdiagnosis and stage migration of ISUP 2 disease due to mpMRI-targeted biopsy: facts or fictions.
Martini A, Touzani A, Mazzone E, Roumiguié M, Marra G, Valerio M, Beauval JB, Campi R, Minervini A, van den Berg RCN, Soeterik TFW, Zhuang J, Guo H, Gontero P, Montorsi F, Briganti A, Gandaglia G, Ploussard G; Young Academic Urologists Working Group on Prostate Cancer of the European Association of Urology. Martini A, et al. Prostate Cancer Prostatic Dis. 2022 Apr;25(4):794-796. doi: 10.1038/s41391-022-00606-6. Epub 2022 Oct 8. Prostate Cancer Prostatic Dis. 2022. PMID: 36209238
External validation of an algorithm to personalize nerve sparing approaches during robot-assisted radical prostatectomy in men with unilateral high-risk prostate cancer.
Rodriguez-Sanchez L, Martini A, Zhuang J, Guo H, Rajwa P, Mandoorah Q, Haiquel L, Shariat SF, Gandaglia G, Valerio M, Marra G; Young Academic Urologists Working Group on Prostate Cancer of the European Association of Urology. Rodriguez-Sanchez L, et al. Prostate Cancer Prostatic Dis. 2024 Jan 4. doi: 10.1038/s41391-023-00779-8. Online ahead of print. Prostate Cancer Prostatic Dis. 2024. PMID: 38177256
An updated model for predicting side-specific extraprostatic extension in the era of MRI-targeted biopsy.
Martini A, Wever L, Soeterik TFW, Rakauskas A, Fankhauser CD, Grogg JB, Checcucci E, Amparore D, Haiquel L, Rodriguez-Sanchez L, Ploussard G, Qiang P, Affentranger A, Marquis A, Marra G, Ettala O, Zattoni F, Falagario UG, De Angelis M, Kesch C, Apfelbeck M, Al-Hammouri T, Kretschmer A, Kasivisvanathan V, Preisser F, Lefebvre E, Olivier J, Radtke JP, Carrieri G, Moro FD, Boström P, Jambor I, Gontero P, Chiu PK, John H, Macek P, Porpiglia F, Hermanns T, van den Bergh RCN, van Basten JA, Gandaglia G, Valerio M; Young Academic Urologists working group on Prostate Cancer of the European Association of Urology. Martini A, et al. Prostate Cancer Prostatic Dis. 2024 Jan 5. doi: 10.1038/s41391-023-00776-x. Online ahead of print. Prostate Cancer Prostatic Dis. 2024. PMID: 38182804
Finally, a regression tree was employed to identify three risk categories to assist urologists in selecting candidates for nerve-sparing, incremental nerve sparing and non-nerve-sparing surgery. ...
Finally, a regression tree was employed to identify three risk categories to assist urologists in selecting candidates for nerve-spar …
Correction to: Overdiagnosis and stage migration of ISUP 2 disease due to mpMRI-targeted biopsy: facts or fictions.
Martini A, Touzani A, Mazzone E, Roumiguié M, Marra G, Valerio M, Beauval JB, Campi R, Minervini A, van den Berg RCN, Soeterik TFW, Zhuang J, Guo H, Gontero P, Montorsi F, Briganti A, Gandaglia G, Ploussard G; Young Academic Urologists Working Group on Prostate Cancer of the European Association of Urology. Martini A, et al. Prostate Cancer Prostatic Dis. 2023 Dec;26(4):806. doi: 10.1038/s41391-022-00637-z. Prostate Cancer Prostatic Dis. 2023. PMID: 36670304 No abstract available.